Success Metrics

Clinical Success Rate
94.3%

Based on 148 completed trials

Completion Rate
94%(148/157)
Active Trials
34(14%)
Results Posted
13%(19 trials)
Terminated
9(4%)

Phase Distribution

Ph early_phase_1
1
0%
Ph phase_4
15
6%
Ph phase_2
8
3%
Ph phase_3
11
5%
Ph phase_1
4
2%
Ph not_applicable
184
77%

Phase Distribution

5

Early Stage

8

Mid Stage

26

Late Stage

Phase Distribution223 total trials
Early Phase 1First-in-human
1(0.4%)
Phase 1Safety & dosage
4(1.8%)
Phase 2Efficacy & side effects
8(3.6%)
Phase 3Large-scale testing
11(4.9%)
Phase 4Post-market surveillance
15(6.7%)
N/ANon-phased studies
184(82.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

90.2%

148 of 164 finished

Non-Completion Rate

9.8%

16 ended early

Currently Active

34

trials recruiting

Total Trials

240

all time

Status Distribution
Active(54)
Completed(148)
Terminated(16)
Other(22)

Detailed Status

Completed148
Recruiting24
unknown22
Not yet recruiting17
Active, not recruiting10
Terminated9

Development Timeline

Analytics

Development Status

Total Trials
240
Active
34
Success Rate
94.3%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (0.4%)
Phase 14 (1.8%)
Phase 28 (3.6%)
Phase 311 (4.9%)
Phase 415 (6.7%)
N/A184 (82.5%)

Trials by Status

active_not_recruiting104%
enrolling_by_invitation31%
not_yet_recruiting177%
withdrawn73%
unknown229%
completed14862%
recruiting2410%
terminated94%

Recent Activity

Clinical Trials (240)

Showing 20 of 240 trialsScroll for more
NCT07844668Not Applicable

Microbiome, Dietary and Quality of Life Analysis of People Living With CVID Treated With or Without Immunoglobulins.

Enrolling By Invitation
NCT03539666Not Applicable

Effect of Diets on the Gut Microbiota Composition and Cardiometabolic Wellbeing

Completed
NCT00422006Not Applicable

Study of the Role of PCSK9 and FXR in the Physiopathology of the Joint Dyslipidemia Associated to the Human Immunoresistance

Completed
NCT05785884Not Applicable

Diet Interventions: Remitted and Evaluated as Complementary Treatments for Pain

Recruiting
NCT07755982Not Applicable

Effects of Intermittent Fasting Variations on Nutrigenomic Profile, Metabolic Parameters, Inflammation, and Body Composition in Prediabetic Patients

Not Yet Recruiting
NCT07692646Not Applicable

The Effect of Fasting on Peak Fat Oxidation, Mitochondrial Coupling and Extracellular Matrix

Recruiting
NCT06640179Not Applicable

Feasibility and Plausible Effectiveness of a Lifestyle Intervention in Kidney Transplant Recipients (HEAL)

Recruiting
NCT06860880Not Applicable

Combating Cancer-Related Fatigue: A Personalized Supportive Care Program

Recruiting
NCT07443293Phase 2

IMPACT 360 for Parkinson's Disease

Active Not Recruiting
NCT07659093Not Applicable

Comparing Intermittent Fasting, Clean Ketogenic Diet, and Their Combined Effects on Body Composition, Cardiometabolic Markers, and Metabolic Health

Completed
NCT05519644Not Applicable

Strategies to Augment Ketosis: Ketone Conferred Resiliency Against Sleep Restriction

Active Not Recruiting
NCT07611162Phase 4

Comparative Effectiveness of Alginate, Magaldrate, Sucralfate, Proton Pump Inhibitors, and Diet in Laryngopharyngeal Reflux Disease

Not Yet Recruiting
NCT07289672Not Applicable

Food Limitations In Crohn's Disease and Ulcerative coliTis

Enrolling By Invitation
NCT05973539Not Applicable

Blood Lipid Responses to Diet Macronutrients

Recruiting
NCT06912555Not Applicable

Effect of Low-calorie Diets With Different Macronutrient Composition and Macronutrient Distribution in Shift Workers With Prediabetes or Type 2 Diabetes and Overweight or Obesity.

Completed
NCT06916390Phase 4

GUselkumAb inteRvention and DIet evaluAtioN for Pouchitis

Recruiting
NCT07509671Not Applicable

The Treatment of Painful Diabetic Neuropathy With Diet

Recruiting
NCT07543016Not Applicable

Amino Acids and Exercise in FSHD

Recruiting
NCT05578690Not Applicable

Healthy Lifestyle Before and During Pregnancy to Prevent Childhood Obesity - the PRE-STORK-trial

Active Not Recruiting
NCT07533513Not Applicable

Effects and Mechanisms of Dietary Carbohydrate Intake and Quality on Glucose and Lipid Metabolism

Not Yet Recruiting

Drug Details

Intervention Type
OTHER
Total Trials
240